BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7141740)

  • 1. Human melanoma cells can be killed in vitro by an immunotoxin specific for melanoma-associated antigen p97.
    Casellas P; Brown JP; Gros O; Gros P; Hellström I; Jansen FK; Poncelet P; Roncucci R; Vidal H; Hellström KE
    Int J Cancer; 1982 Oct; 30(4):437-43. PubMed ID: 7141740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent cytotoxicity of an auristatin-containing antibody-drug conjugate targeting melanoma cells expressing melanotransferrin/p97.
    Smith LM; Nesterova A; Alley SC; Torgov MY; Carter PJ
    Mol Cancer Ther; 2006 Jun; 5(6):1474-82. PubMed ID: 16818506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues.
    Brown JP; Woodbury RG; Hart CE; Hellström I; Hellström KE
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):539-43. PubMed ID: 6165996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Workshop on monoclonal antibodies to human melanoma-associated antigens: findings of the Seattle group.
    Hellström I; Brown JP; Hellström KE
    Hybridoma; 1982; 1(4):399-402. PubMed ID: 6208136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy.
    Estin CD; Stevenson US; Plowman GD; Hu SL; Sridhar P; Hellström I; Brown JP; Hellström KE
    Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1052-6. PubMed ID: 3422478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue specificity of anti melanoma monoclonal antibodies analyzed on cell lines.
    Johnson JP; Riethmüller G
    Hybridoma; 1982; 1(4):381-5. PubMed ID: 6208134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the NIH workshop monoclonal antibodies to human melanoma antigens.
    Kantor RR; Ng AK; Giacomini P; Ferrone S
    Hybridoma; 1982; 1(4):473-82. PubMed ID: 6208142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and isolation of melanoma-associated antigens with monoclonal antibodies.
    Ross AH; Mitchell KF; Steplewski Z; Koprowski H
    Hybridoma; 1982; 1(4):413-21. PubMed ID: 6765324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antiidiotypic antibodies related to the p97 human melanoma antigen.
    Kahn M; Hellström I; Estin CD; Hellström KE
    Cancer Res; 1989 Jun; 49(12):3157-62. PubMed ID: 2470502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of HC antibody in autologous tumor-specific cytotoxicity by human melanoma tumor-infiltrating lymphocytes.
    Mansfield PF; Salmeron MA; Rosenblum MG; Itoh K
    Int J Cancer; 1991 Sep; 49(3):356-61. PubMed ID: 1917133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of melanoma-associated antigen p97 in cultured human melanoma, as visualized by light and electron microscopy.
    Tilgen W; Hellström I; Engstner M; Garrigues HJ; Riehl R; Hellström KE
    J Invest Dermatol; 1983 May; 80(5):459-63. PubMed ID: 6842000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological analysis of melanoma-specific antigen].
    Wakabayashi S; Okamoto S
    Nihon Hifuka Gakkai Zasshi; 1985 Oct; 95(11):1145-51. PubMed ID: 3879298
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of hybridoma-exchange antibodies.
    Lloyd KO; Albino A; Houghton A
    Hybridoma; 1982; 1(4):461-3. PubMed ID: 6208140
    [No Abstract]   [Full Text] [Related]  

  • 14. CD4+ T cell clones specific for the human p97 melanoma-associated antigen can eradicate pulmonary metastases from a murine tumor expressing the p97 antigen.
    Kahn M; Sugawara H; McGowan P; Okuno K; Nagoya S; Hellström KE; Hellström I; Greenberg P
    J Immunol; 1991 May; 146(9):3235-41. PubMed ID: 1707934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
    Saxton RE; Mann BD; Morton DL; Burk MW
    Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma-associated antigen p97 continues to be expressed after prolonged exposure of cells to specific antibody.
    Hellström I; Brown JP; Hellström KE
    Int J Cancer; 1983 May; 31(5):553-5. PubMed ID: 6852973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological and biochemical analyses of monoclonal antibodies to human melanoma-associated antigens.
    Harper JR; Bumol TF; Reisfeld RA
    Hybridoma; 1982; 1(4):423-32. PubMed ID: 6208137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the binding parameters to melanoma cells of antihuman high molecular weight-melanoma associated antigen (HMW-MAA) monoclonal antibodies (mAb) and syngeneic anti-anti-idiotypic (anti-anti-id) mAb.
    Chen ZJ; Ferrone S
    Ann N Y Acad Sci; 1993 Aug; 690():398-401. PubMed ID: 8368768
    [No Abstract]   [Full Text] [Related]  

  • 19. Melanoma localization in nude mice with monoclonal Fab against p97.
    Beaumier PL; Krohn KA; Carrasquillo JA; Eary J; Hellström I; Hellström KE; Nelp WB; Larson SM
    J Nucl Med; 1985 Oct; 26(10):1172-9. PubMed ID: 4045562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of in vitro tumor-infiltrating lymphocyte cytotoxicity by heteroconjugated antibodies.
    Reid I; Lundy J; Donohue JH
    J Immunol; 1992 Apr; 148(8):2630-5. PubMed ID: 1532818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.